A detailed history of Htlf Bank transactions in Eli Lilly & CO stock. As of the latest transaction made, Htlf Bank holds 772 shares of LLY stock, worth $592,710. This represents 0.07% of its overall portfolio holdings.

Number of Shares
772
Previous 848 8.96%
Holding current value
$592,710
Previous $768 Million 10.92%
% of portfolio
0.07%
Previous 0.09%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$772.14 - $960.02 $58,682 - $72,961
-76 Reduced 8.96%
772 $684 Million
Q2 2024

Jul 23, 2024

BUY
$724.87 - $909.04 $55,090 - $69,087
76 Added 9.84%
848 $768 Million
Q1 2024

Apr 25, 2024

BUY
$592.2 - $792.28 $6,514 - $8,715
11 Added 1.45%
772 $601 Million
Q4 2023

Jan 31, 2024

BUY
$525.19 - $619.13 $399,669 - $471,157
761 New
761 $444 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Htlf Bank Portfolio

Follow Htlf Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Htlf Bank, based on Form 13F filings with the SEC.

News

Stay updated on Htlf Bank with notifications on news.